Zobrazeno 1 - 10
of 607
pro vyhledávání: '"Jing Zhao"'
Autor:
Yan Zhang, Jing Zhao, Yajun Wang, Wei Cai, Xiaoli Zhang, Kaifu Li, Wenqing Liu, Ye Zhao, Hua Kang
Publikováno v:
Disease Markers. 2022:1-14
Objective. Serum tumor marker (STM) elevation can detect metastasis earlier than imaging diagnosis and, although not recommended by guidelines, is still widely used in clinical practice for postoperative follow-up of breast cancer patients. The purpo
Autor:
Yuequan Shi, Jian Fang, Chengzhi Zhou, Anwen Liu, Yan Wang, Qingwei Meng, Cuimin Ding, Bin Ai, Yangchun Gu, Yu Yao, Hong Sun, Hui Guo, Cuiying Zhang, Xia Song, Junling Li, Bei Xu, Zhiqiang Han, Meijun Song, Tingyu Tang, Peifeng Chen, Hongmin Lu, Yongjie Shui, Guangyuan Lou, Dongming Zhang, Jia Liu, Xiaoyan Liu, Xiangning Liu, Xiaoxing Gao, Qing Zhou, Minjiang Chen, Jing Zhao, Wei Zhong, Yan Xu, Mengzhao Wang
Publikováno v:
Thoracic Cancer, Vol 13, Iss 3, Pp 412-422 (2022)
Thoracic Cancer
Thoracic Cancer
Background Immune checkpoint inhibitors (ICIs) are the standard treatment for advanced lung cancer, but immune‐related adverse events (irAEs) remain poorly understood, especially in a real‐world setting. Methods A multicenter observational study
Autor:
Jun Zuo, Weixia Li, Jing Zhao, Rui-Song Gong, Panpan Zhang, Xiaowen Liu, Ruihua Sun, Mercedes Susan Mandell
Publikováno v:
British Journal of Anaesthesia. 128:45-54
Perioperative anaphylaxis is relatively rare but can be life-threatening. The incidence in China is unknown and may differ from other global geographic regions. This study was therefore designed to understand the incidence of perioperative anaphylaxi
Autor:
Minjiang Chen, Mengzhao Wang, Jing Zhao, Jia Liu, Wei Zhong, Dongming Zhang, Yuequan Shi, Yan Xu, Xiaoyan Liu, Juan Du
Publikováno v:
Thoracic Cancer, Vol 13, Iss 2, Pp 219-227 (2022)
Thoracic Cancer
Thoracic Cancer
Background Pretreatment and on‐treatment plasma cytokine levels in predicting clinical benefit in patients with advanced non‐small cell lung cancer (NSCLC) treated with anti‐programmed death‐1 (PD‐1)‐based chemotherapy is still a matter o
Autor:
Lanfang Li, Xianhuo Wang, Jin He, Sicong Zhang, Bin Meng, Jing Zhao, Xiaoxing Su, Shiyong Zhou, Lihua Qiu, Hengqi Liu, Tingting Zhang, Huilai Zhang, Xiubao Ren, Zhengzi Qian, Haifei Zhou, Xianming Liu, Wenchen Gong
Publikováno v:
British Journal of Haematology. 196:617-628
Diffuse large B-cell lymphoma (DLBCL) is a highly heterogenous malignancy, early identification of patients for relapse remains challenging. The potential to non-invasively monitor tumour evolutionary dynamics of DLBCL needs to be further established
Autor:
Xuyu Bian, Dao-Ming Li, Bingjie Ren, Jing Zhao, Yuanyuan Yang, Rongrui Liang, Min Tao, Fengling Shi, Caihua Xu
Publikováno v:
Annals of Palliative Medicine. 10:9725-9731
Bone is among the most common metastasis sites in patients with advanced cancer. Approximately two-thirds of bone metastasis results in pain, the majority of which is moderate to unbearable pain, which seriously affects the quality of life of patient
Autor:
Xiaoxuan Sun, Yaojun Peng, Juan Yang, Qiyan Wu, Dong Zhang, Huan Wang, Qi Chen, Jing Zhao, Gaowa Sharen, Fan Yin
Publikováno v:
FEBS Open Bio, Vol 11, Iss 9, Pp 2490-2506 (2021)
FEBS Open Bio
FEBS Open Bio
The accumulation of various genetic and epigenetic changes in colonic epithelial cells has been identified as one of the fundamental processes that drive the initiation and progression of colorectal cancer (CRC). This study aimed to explore functiona
Autor:
Zhengyu Zhang, Mulan Jin, Meizhu Xiao, Jing Zhao, Meiying Song, Haiteng Deng, Weihua Li, Huimin Bai, Ruili Jiao
Publikováno v:
Journal of Cellular and Molecular Medicine
Objective The present study was aimed to determine the differentially expressed proteins (DEPs) between paired samples of cervical cancer (CC) and paracancerous tissue by quantitative proteomics and to examine the effects of DUSP7 expression on tumor
Publikováno v:
Thoracic Cancer
Thoracic Cancer, Vol 12, Iss 17, Pp 2339-2344 (2021)
Thoracic Cancer, Vol 12, Iss 17, Pp 2339-2344 (2021)
Background Programmed cell death ligand‐1 (PD‐L1) is a useful biomarker in non‐small cell lung cancer (NSCLC) patients who would probably benefit from immunotherapy. In most patients with advanced stage NSCLC, only small biopsy specimens were a
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 40:2515-2523
Growing evidence suggests that autoimmune diseases (AIDs) are risk factors for cryptococcal meningitis (CM). Therefore, understanding the epidemiological and clinical profile of CM in patients with AIDs is important. This meta-analysis assessed the p